Thursday, May 19, 2022

Update to PharmGKB Pediatric Summaries - BPCA Drugs

The latest round of PharmGKB’s pediatric drug summaries is now live on PharmGKB pediatric. This release includes summaries for 55 drugs, bringing the total summary count to over 180, now including all drugs on the Best Pharmaceuticals for Children Act (BPCA) priority list in addition to all CPIC guideline drugs.

Drugs with new summaries include:
  • Alfentanil
  • Amiodarone
  • Ampicillin
  • Azithromycin
  • Bosentan
  • Cidofovir
  • Ciprofloxacin
  • Clindamycin
  • Clonidine
  • Dexmedetomidine
  • Digoxin
  • Doxycycline
  • Furosemide
  • Granisetron
  • Griseofulvin
  • Heparin
  • Hydralazine
  • Hydrochlorothiazide
  • Hydromorphone
  • Hydroxycobalamin
  • Hydroxyurea
  • Isotretinoin
  • Labetalol
  • Levofloxacin
  • Levothyroxine
  • Lidocaine
  • Lisinopril
  • Lithium
  • Lorazepam
  • Lurasidone
  • Meropenem
  • Metformin
  • Methylprednisolone
  • Midazolam
  • Molindone
  • Nafcillin
  • Nicardipine
  • Nifedipine
  • Nifurtimox
  • Olanzapine
  • Pentobarbital
  • Piperacillin-Tazobactam
  • Pralidoxime
  • Prednisolone
  • Sertraline
  • Sildenafil
  • Spironolactone
  • Terbutaline
  • Timolol
  • Topiramate
  • Tranexamic Acid
  • Valganciclovir
  • Vancomycin
  • Vecuronium

No comments: